Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $5.94 billion. The enterprise value is $5.31 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COGT has 170.91 million shares outstanding. The number of shares has increased by 6.75% in one year.
| Current Share Class | 170.87M |
| Shares Outstanding | 170.91M |
| Shares Change (YoY) | +6.75% |
| Shares Change (QoQ) | +8.12% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 102.22% |
| Float | 160.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 10.93 |
| P/TBV Ratio | 10.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.14, with a Debt / Equity ratio of 0.39.
| Current Ratio | 15.14 |
| Quick Ratio | 14.94 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -84.69 |
Financial Efficiency
Return on equity (ROE) is -85.72% and return on invested capital (ROIC) is -41.81%.
| Return on Equity (ROE) | -85.72% |
| Return on Assets (ROA) | -38.13% |
| Return on Invested Capital (ROIC) | -41.81% |
| Return on Capital Employed (ROCE) | -42.84% |
| Weighted Average Cost of Capital (WACC) | 6.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.37M |
| Employee Count | 258 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +636.02% in the last 52 weeks. The beta is 0.37, so COGT's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +636.02% |
| 50-Day Moving Average | 36.22 |
| 200-Day Moving Average | 28.09 |
| Relative Strength Index (RSI) | 39.95 |
| Average Volume (20 Days) | 1,664,604 |
Short Selling Information
The latest short interest is 12.04 million, so 7.04% of the outstanding shares have been sold short.
| Short Interest | 12.04M |
| Short Previous Month | 17.43M |
| Short % of Shares Out | 7.04% |
| Short % of Float | 7.48% |
| Short Ratio (days to cover) | 4.69 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -362.04M |
| Pretax Income | -354.30M |
| Net Income | -354.30M |
| EBITDA | -359.49M |
| EBIT | -362.04M |
| Earnings Per Share (EPS) | -$2.51 |
Full Income StatementBalance Sheet
The company has $866.38 million in cash and $238.65 million in debt, with a net cash position of $627.73 million or $3.67 per share.
| Cash & Cash Equivalents | 866.38M |
| Total Debt | 238.65M |
| Net Cash | 627.73M |
| Net Cash Per Share | $3.67 |
| Equity (Book Value) | 607.69M |
| Book Value Per Share | 3.18 |
| Working Capital | 819.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$284.82 million and capital expenditures -$1.46 million, giving a free cash flow of -$286.27 million.
| Operating Cash Flow | -284.82M |
| Capital Expenditures | -1.46M |
| Depreciation & Amortization | 2.55M |
| Net Borrowing | 217.76M |
| Free Cash Flow | -286.27M |
| FCF Per Share | -$1.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.75% |
| Shareholder Yield | -6.75% |
| Earnings Yield | -5.97% |
| FCF Yield | -4.82% |
Analyst Forecast
The average price target for COGT is $36.43, which is 4.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.43 |
| Price Target Difference | 4.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.
| Last Split Date | Nov 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
